These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28366579)

  • 21. Treatment of T1-T2 rectal tumors by contact therapy and interstitial brachytherapy.
    Coatmeur O; Truc G; Barillot I; Horiot JC; Maingon P
    Radiother Oncol; 2004 Feb; 70(2):177-82. PubMed ID: 15028405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined neutron brachytherapy with external beam radiation in patients with inoperable gastroesophageal junction adenocarcinoma.
    Wang Q; Liu H; Jia X; Liu B; Wan X
    Tumori; 2014; 100(4):470-5. PubMed ID: 25296599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose-rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma.
    Corner C; Bryant L; Chapman C; Glynne-Jones R; Hoskin PJ
    Brachytherapy; 2010; 9(1):66-70. PubMed ID: 19846349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Image-guided high-dose-rate brachytherapy for rectal cancer: technical note and first clinical experience on an organ-preserving approach.
    Fleischmann M; Diefenhardt M; Trommel M; Scherf C; Ramm U; Chatzikonstantinou G; Fokas E; Rödel C; Tselis N
    Strahlenther Onkol; 2022 Jul; 198(7):654-662. PubMed ID: 35445815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?
    Sun Myint A; Mukhopadhyay T; Ramani VS; Perkins K; Snee AJ; Jelley F; Wong H; Lee CD
    Colorectal Dis; 2010 Aug; 12 Suppl 2():30-6. PubMed ID: 20618365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective phase II study of brachytherapy boost as a component of neo-adjuvant chemotherapy and external beam radiation therapy in locally advanced rectal cancer.
    El-Sayed ME; El-Taher ZH
    J Egypt Natl Canc Inst; 2008 Mar; 20(1):10-6. PubMed ID: 19847277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study.
    Appelt AL; Pløen J; Harling H; Jensen FS; Jensen LH; Jørgensen JC; Lindebjerg J; Rafaelsen SR; Jakobsen A
    Lancet Oncol; 2015 Aug; 16(8):919-27. PubMed ID: 26156652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II study of preoperative helical tomotherapy with a simultaneous integrated boost for rectal cancer.
    Engels B; Tournel K; Everaert H; Hoorens A; Sermeus A; Christian N; Storme G; Verellen D; De Ridder M
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):142-8. PubMed ID: 22014952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term results of high-dose-rate brachytherapy in the primary treatment of medically inoperable stage I-II endometrial carcinoma.
    Niazi TM; Souhami L; Portelance L; Bahoric B; Gilbert L; Stanimir G
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1108-13. PubMed ID: 16099598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
    Zhang M; Xu HD; Pan SD; Lin S; Yue JH; Liu JR
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):966-71. PubMed ID: 22138462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereotactic Body Radiation Therapy Boost After Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer: A Phase 1 Dose Escalation Study.
    Hepel JT; Leonard KL; Safran H; Ng T; Taber A; Khurshid H; Birnbaum A; ; Wazer DE; DiPetrillo T
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1021-1027. PubMed ID: 27745983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative chemoradiation of locally advanced T3 rectal cancer combined with an endorectal boost.
    Jakobsen A; Mortensen JP; Bisgaard C; Lindebjerg J; Hansen JW; Rafaelsen SR
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):461-5. PubMed ID: 16226396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Feasibility and toxicity of a single fraction high-dose-rate brachytherapy followed by a course of EBRT for localized prostate cancer: a retrospective study. The Polyclinique Courlancy experience].
    Mallet F; Wdowczyk D; Bruna A; Villena P; Herard A; Amory JP; Joffroy P; Pangrazzi T
    Cancer Radiother; 2010 Jan; 14(1):11-8. PubMed ID: 20005765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endobronchial brachytherapy and optimization of local disease control in medically inoperable non-small cell lung carcinoma: a matched-pair analysis.
    Mantz CA; Dosoretz DE; Rubenstein JH; Blitzer PH; Katin MJ; Garton GR; Nakfoor BM; Siegel AD; Tolep KA; Hannan SE; Dosani R; Feroz A; Maas C; Bhat S; Panjikaran G; Lalla S; Belani K; Ross RH
    Brachytherapy; 2004; 3(4):183-90. PubMed ID: 15607149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma.
    Pasquier D; Mirabel X; Adenis A; Rezvoy N; Hecquet G; Fournier C; Coche-Dequeant B; Prevost B; Castelain B; Lartigau E
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1456-61. PubMed ID: 16863928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CT-based adaptive high-dose-rate endorectal brachytherapy in the preoperative treatment of locally advanced rectal cancer: Technical and practical aspects.
    Nout RA; Devic S; Niazi T; Wyse J; Boutros M; Pelsser V; Vuong T
    Brachytherapy; 2016; 15(4):477-484. PubMed ID: 27090225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.
    Wang CJ; Huang EY; Sun LM; Chen HC; Fang FM; Hsu HC; Changchien CC; Leung SW
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):179-89. PubMed ID: 15093915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
    Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.